Saikosaponin B2

CAS No. 58316-41-9

Saikosaponin B2( —— )

Catalog No. M18845 CAS No. 58316-41-9

Saikosaponin B2 acts on HCV E2 and inhibits infection by several genotypic strains and prevents binding of serum-derived HCV onto hepatoma cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 75 In Stock
10MG 130 In Stock
25MG 239 In Stock
50MG 350 In Stock
100MG 525 In Stock
200MG Get Quote In Stock
500MG 1144 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Saikosaponin B2
  • Note
    Research use only, not for human use.
  • Brief Description
    Saikosaponin B2 acts on HCV E2 and inhibits infection by several genotypic strains and prevents binding of serum-derived HCV onto hepatoma cells.
  • Description
    Saikosaponin B2 acts on HCV E2 and inhibits infection by several genotypic strains and prevents binding of serum-derived HCV onto hepatoma cells. Saikosaponin B2 (5 μM) induces differentiation of B16 melanoma cells, with potentiation of expressions of tyrosinase and melanogenesis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Reductase
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    58316-41-9
  • Formula Weight
    780.99
  • Molecular Formula
    C42H68O13
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (128.04 mM)
  • SMILES
    C[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]1CC[C@]2([C@H]([C@]1(C)CO)CC[C@@]1([C@@H]2C=CC2=C3CC(CC[C@@]3([C@@H](C[C@@]12C)O)CO)(C)C)C)C)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lin LT,et al. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry. J Hepatol. 2015 Mar;62(3):541-8. doi: 10.
molnova catalog
related products
  • Imirestat

    Imirestat is an aldose reductase inhibitor that can be used in diabetes research.

  • CH5138303

    CH5138303 is an orally available Hsp90 inhibitor with Kd of 0.48 nM.

  • Lidorestat

    Lidorestat (IDD-676) is an aldose reductase inhibitor (IC50: 5 nM) with effective, selective and oral activity. Lidorestat improves nerve conduction and reduces the formation of cataracts.